Irene Owusu Donkor, PhD profile image

Irene Owusu Donkor, PhD

SENIOR RESEARCH FELLOW

Verified email at noguchi.ug.edu.gh Noguchi Memorial Institute for Medical Research, University of Ghana Google Scholar

CollegeCOLLEGE OF HEALTH SCIENCES
School / InstituteNOGUCHI MEM. INST. FOR MED.RES
DepartmentDEPARTMENT OF EPIDEMIOLOGY
EpidemiologyInfectious DiseasesDisease Control
Publications

20

Citations

208

H-index

7

i10-index

5

Publication activity
Publication statistics
Average citations
10.4
Most cited paper
116
First publication year
1851
Latest publication year
2026
Last updated
14 Sep 2026, 11:12
Publications

20 matching publications

PublicationYearJournalThematic areaCitations
Elimination of lymphatic filariasis: current perspectives on mass drug administration
MG John O Gyapong, Irene O Owusu, Frances B da-Costa Vroom, Ernest O Mensah
2018 Res Rep Trop Med, 2018 Health Sciences 116
OraSure InteliSwab™ Rapid Antigen Test Performance with the SARS-CoV-2 Variants of Concern—Alpha, Beta, Gamma, Delta, and Omicron
ZA Weishampel, J Young, M Fischl, RJ Fischer, IO Donkor, JC Riopelle, ...
2022 Viruses 14 (3), 543, 2022 Health Sciences 27
RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa
C Fischer, TG Maponga, A Yadouleton, N Abilio, E Aboce, P Adewumi, ...
2022 Science, eadd8737, 2022 Health Sciences 18
Modeling SARS-CoV-2 Antibody Seroprevalence and its Determinants in Ghana: A Nationwide Cross-Sectional Survey
I Owusu Donkor, SK Mensah, D Dwomoh, J Akorli, B Abuaku, Y Ashong, ...
1900 Health Sciences 13
An evaluation of Wb123 antibody elisa in individuals treated with ivermectin and albendazole, and implementation challenges in Africa
MDW Dziedzom Komi de Souza, Irene Offei Owusu, Joseph Otchere, Michelle ...
2017 Pan Afr Med J ., 2017 Health Sciences 10
Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana
K Tapela, PC Opurum, FY Nuokpem, B Tetteh, GK Siaw, MV Humbert, ...
2023 Molecular Diagnosis & Therapy 27 (5), 583-592, 2023 Natural Sciences 9
A global collaborative comparison of SARS-CoV-2 antigenicity across 15 laboratories
P Brangel, S Tureli, B Mühlemann, N Liechti, D Zysset, O Engler, ...
2024 Viruses 16 (12), 1936, 2024 Health Sciences 7
Evaluation of SARS-CoV-2 seroprevalence and variant distribution during the delta–omicron transmission waves in Greater Accra, Ghana, 2021
ES Lomotey, J Akorli, M Opoku, DA Odumang, K Nketia, EF Gyekye, ...
2025 Viruses 17 (4), 487, 2025 Health Sciences 4
Assessing the performance of regular surgical nose masks as a sampling method for SARS-CoV-2 detection in a cross-sectional study
M Opoku, E Obeng-Aboagye, GYK Boamah, D Adu-Asamoah, RY Ismail, ...
2023 Plos one 18 (10), e0293001, 2023 Health Sciences 2
Lessons learnt during the implementation of Unity‐aligned SARS‐CoV‐2 seroprevalence studies in Africa
E Farley, J Okeibunor, T Balde, IO Donkor, J Kleynhans, JF Wamala, ...
2023 Influenza and Other Respiratory Viruses 17 (8), e13170, 2023 Health Sciences 1
Regular deworming and seasonality are potential challenges but also offer opportunities for hookworm elimination
ANL Lamptey, IA Larbi, IOO Donkor, JG Sumboh, Y Ashong, D Osabutey, ...
2023 medRxiv, 2023 Health Sciences 1
High prevalence of human coronaviruses in rural and urban Ghana in the post-COVID-19 era
ES Lomotey, M Montiel-Ruiz, DA Odumang, E Obeng-Aboagye, ...
2026 Frontiers in Epidemiology 6, 1874054, 2026 Health Sciences 0
Post-Pandemic Neutralizing Antibody Responses to SARS-CoV-2 D614G Variant in Rural and Urban Ghana
ES Lomotey, IA Owusu, EA Kisser, K Nketia, DK Mensah, AS Dayi, ...
2026 Viruses 18 (4), 414, 2026 Social Sciences 0
Seroprevalence of SARS-CoV-2 neutralizing antibodies among travelers entering Ghana through major land borders, pre-and post-opening of borders, 2022
IO Donkor, ES Lomotey, DA Odumang, AG Mohammed, IA Asante, ...
2026 BMC Infectious Diseases 26 (1), 1034, 2026 Health Sciences 0
SARS- CoV- 2 infection in Africa: a systematic review and meta- analysis of standardized seroprevalence studies, from January 2020 to December 2021
2022 Health Sciences 0
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
2021 Health Sciences 0
SARS-CoV-2 disease severity and transmission efficiency is increased for airborne compared to fomite exposure in Syrian hamsters
2021 Health Sciences 0
Evaluation of human and mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lymphatic filariasis in Ghana
2015 Transactions of the Royal Society of Tropical Medicine and Hygiene, 2015 Health Sciences 0
Transmission Assessment Surveys (TAS) to define endpoints for lymphatic filariasis mass drug administration: A multicenter evaluation
2013 PLoS NTDs, 2013 Health Sciences 0
Modeling SARS-CoV-2 antibody seroprevalence and its determinants in Ghana: A nationally representative cross-sectional survey. PLOS Glob Public Health 3 (5): e0001851
I Owusu Donkor, SK Mensah, D Dwomoh, J Akorli, B Abuaku, Y Ashong
1851 Health Sciences 0